Emerging Microbiota-Based Drugs
Research focuses on developing therapeutics derived from microbiome science. This includes engineered bacteria, live biotherapeutics, and metabolite-based drugs. Studies evaluate pharmacokinetics, safety, and targeted mechanisms of action. The journal highlights innovations that bridge microbiology and pharmaceutical sciences. These advances shape the future of microbiome-driven drug discovery.